Cannabis sativa extracts demonstrate potential to in COVID-19 treatment

By Akshay Kedari  | Date: 2020-04-23

Cannabis sativa extracts demonstrate potential to in COVID-19 treatment

The University of Lethbridge, with Swysh, a company focused on cannabinoid R&D and Pathway Rx, a research company focused on developing custom cannabis therapies, are partnering to unravel a specific Cannabis sativa extract that shows potential as an additional treatment for the novel coronavirus.

Dr. Igor Kovalchuks, Chief Executive Officer at Pathway RX and Dr. Olga Kovalchuk, (both are professors at The University of Lethbridge) reportedly said that although one of their most successful cannabis sativa extracts require further validation in an animal model as well as in a large-scale analysis, the study is crucial for the examination of the effects of medical cannabis on coronavirus.

A team of researchers and Kovalchuks recently submitted their paper to a journal for publication. The paper represents extensive research study on the effects of medical cannabis on COVID-19. The manuscript of the paper has been uploaded on Preprints. However, it signifies that the research has not yet been peer reviewed or been published in a journal.

As per sources close to the matter, the study is focused on how different cannabis extracts affect TMPRSS2 and ACE2 proteins. These proteins are rooted into the cellular membrane and are the main gateway for the coronavirus to enter host cells. Used by the researchers, the C. sativa has been analyzed for modulating the levels of these enzymes.

Initial data indicate that 13 cannabis sativa extracts which are high in the anti-inflammatory cannabinoid cannabidiol can modulate ACE2 expression in coronavirus target tissues and may also down-regulate TMPRSS2 proteins. The results establish that these high-cannabinoid C. sativa lines showcase potential to be a safe and useful addition for the treatment of COVID-19.

Estimates suggests that they could be potentially utilized to develop preventative treatments in the form of a throat gargle or mouthwash product for clinical as well as home use.

 

Source credit: https://www.uleth.ca/unews/article/u-l-scientists-develop-new-medical-cannabis-cultivars-show-promise-combatting-covid-19-virus#.XqEcDGYzbcu

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Amazon Smart Commerce to digitize 10 million small businesses in India

Amazon Smart Commerce to digitize 10 million small businesses in India

By Akshay Kedari

E-commerce behemoth Amazon Inc. has reportedly launched a “Smart Commerce” initiative in India, aiming to digitalize 10 million small businesses, allow for USD 10 billion worth in exports, and create 2 million jobs by 2025. During the ...

McDonald’s to leave Russia after 30 years amidst Ukraine’s invasion

McDonald’s to leave Russia after 30 years amidst Ukraine’s invasion

By Akshay Kedari

After Ukraine’s invasion, multinational fast-food giant McDonald's Corp. is reportedly planning to sell all its restaurants in Russia, pulling operations from the nation after 30 years. The world's biggest fast-food chain closed 847 ...

Berlin’s GetHenry bags USD 17.4 Mn seed funding for business expansion

Berlin’s GetHenry bags USD 17.4 Mn seed funding for business expansion

By Akshay Kedari

GetHenry, a Berlin-based company that offers couriers and logistics organizations electric last-mile delivery bikes, has reportedly raised USD 17.4 million seed round to grow its operations across Europe. The latest investment round was led by LocalG...

Ferrari to equip the upcoming Purosangue with its trademark V12 engine

Ferrari to equip the upcoming Purosangue with its trademark V12 engine

By Akshay Kedari

Italian luxury sports car manufacturer Ferrari S.p.A. will equip its much-awaited Purosangue SUV with a 12-cylinder engine, as it focused more on fuel-efficient models. Confirming the news, Ferrari Chief Executive Benedetto Vigna claimed that the com...

White House to spend USD 3 billion on EV battery manufacturing in U.S.

White House to spend USD 3 billion on EV battery manufacturing in U.S.

By Akshay Kedari

According to reliable sources, the Biden administration is planning to provide USD 3 billion in finance to reinforce EV battery manufacturing capabilities in the United States. The apparent funds will be issued by the Department of Energy from Presid...